Rofecoxib associated with diaphragm disease.
Lapner
Michael A
MA
Department of Surgery, McMaster University, Hamilton, ON, Canada.
Stephen
Wesley J
WJ
D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003251:Constriction, Pathologic; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007415:Intestinal Obstruction / Q000139:chemically induced* / Q000473:pathology; D007421:Intestine, Small; D007783:Lactones / Q000009:adverse effects*; D008875:Middle Aged; D012008:Recurrence; D013450:Sulfones / Q000009:adverse effects*
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib